Skip to main content

Press releases | November 6, 2024

Fried Frank acted as counsel to Lazard as financial advisor to Cencora, Inc. (“Cencora”) (NYSE: COR) in its $4.6 billion acquisition of Retina Consultants of America (“RCA”). Cencora is a drug wholesale company and a contract research organization. RCA is a management services organization (MSO) of retina specialists. RCA’s affiliated practices, physicians and management will retain a minority interest in RCA, with Cencora holding approximately 85% ownership in RCA upon closing. 


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.